ETH 255
Pill imprint ETH 255 has been identified as Hyoscyamine sulfate (sublingual) 0.125 mg.
Hyoscyamine is used in the treatment of irritable bowel syndrome; anesthesia; urinary incontinence; crohn's disease; endoscopy or radiology premedication and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy.
Hyoscyamine 0.125 mg is not subject to the Controlled Substances Act.
See also related documents.
Hyoscyamine sulfate (sublingual) Images
- Imprint:
-
ETH 255
- Strength:
- 0.125 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Anticholinergics/antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0255
Advertisement
More Hyoscyamine Sulfate (Sublingual) resources
- Hyoscyamine (Wolters Kluwer)
- Hyoscyamine Controlled-Release Tablets (Wolters Kluwer)
- Hyoscyamine Drops (Wolters Kluwer)
- Hyoscyamine Elixir (Wolters Kluwer)
- Hyoscyamine Extended-Release Capsules (Wolters Kluwer)
- Hyoscyamine Extended-Release Tablets (Wolters Kluwer)
- Hyoscyamine Orally Disintegrating Tablets (Wolters Kluwer)
- Hyoscyamine Spray (Wolters Kluwer)
- Hyoscyamine Tablets (Wolters Kluwer)
- hyoscyamine (Cerner Multum)
- Hyoscyamine (AHFS DI)
- Hyoscyamine Sulfate (AHFS DI)
- Hyoscyamine Sulfate Elixir (FDA)
- Hyoscyamine Sulfate Extended-Release Tablets (FDA)
- Hyoscyamine Sulfate Oral Drops (FDA)
- Hyoscyamine Sulfate Orally Disintegrating Tablet (FDA)
- Hyoscyamine Sulfate Tablet (FDA)
- Oscimin Oral Dispersible Tablet (FDA)
- Oscimin SR Tablets (FDA)
- Oscimin Sublingual Tablet (FDA)
- Oscimin Tablet (FDA)
- Hyoscyamine Sulfate (Wolters Kluwer)
Search Again
